Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.9T | 2.1T | 2.3T | 1.7T |
Cost of revenue | 17.1B | 30.3B | 277.7B | 154.5B |
Gross profit | 1.9T | 2.1T | 2.0T | 1.5T |
Operating expense | ||||
Research & development | — | 10.7B | 11.7B | 11.1B |
Selling general and admin | 470.1B | 314.6B | 217.5B | 208.6B |
Other operating expenses | — | 1.7B | 24.3B | 2.0B |
Operating income | 1.9T | 1.7T | 1.7T | 1.2T |
Non operating interest income | ||||
Income | — | 19.0B | 21.8B | 19.7B |
Expense | — | 4.3B | 4.0B | 4.2B |
Other income expense | — | — | — | — |
Pretax income | 1.5T | 1.7T | 1.5T | 1.2T |
Tax provision | 74.8B | 75.2B | 77.3B | 56.9B |
Net income | 1.4T | 1.6T | 1.5T | 1.1T |
Basic EPS | 10.9K | 12.2K | — | 8.5K |
Diluted EPS | 10.9K | 12.2K | — | 8.5K |
Basic average shares | — | 132.6M | — | 133.3M |
Diluted average shares | — | 133.0M | — | 133.6M |
EBITDA | 1.9T | 1.7T | 1.7T | 1.2T |
Net income from continuing op. | — | 1.6T | 1.5T | 1.1T |
Minority interests | -6.9B | 3.8B | 32.7B | 7.3B |
Preferred stock dividends | — | — | — | — |